The 22nd Century Group yesterday submitted a Modified Risk Tobacco Product application with the US Food and Drug Administration for the company’s very low nicotine content (VLNC) cigarettes.
The company previously filed a Premarket Tobacco Application (PMTA).
‘Together, these important applications seek the FDA’s authorization to commercialize the company’s VLNTM cigarettes and to advertise that the VLNTM cigarettes contain 95 percent less nicotine as compared to the 100 leading cigarette brands in the United States,’ the company said in a press note.
Modified risk claim filed
